echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Letter of the drug administration department of the state health and Family Planning Commission on soliciting public opinions on the proposed implementation of designated production of drug varieties

    Letter of the drug administration department of the state health and Family Planning Commission on soliciting public opinions on the proposed implementation of designated production of drug varieties

    • Last Update: 2016-03-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: health and Family Planning Commission, 2016-3-7, national health and Drug Administration catalog letter [2016] No 19, according to the guidance of the general office of the State Council on improving the centralized drug procurement in public hospitals (GBF [2015] 7) In order to ensure the supply of drugs that are clinically necessary, small in dosage and in short supply in the market, our company has worked out the list of drugs in short supply to be produced at designated points (Appendix) together with relevant parties Now we are open to the public for comments Please provide feedback through the following channels and ways before March 18, 2016 1 Fax to: 010-68792819 2 Email to: liuzhanqiang@nhfpc.gov.cn 3 Mail to: No.1, Xizhimenwai South Road, Xicheng District, Beijing City, basic drug catalogue office, drug administration department, national health and Family Planning Commission, postcode 100044 Annex: list of drug varieties to be produced at designated points (Draft for comments) On March 4, 2016, the drug administration department of the national health and Family Planning Commission proposed to implement the list of drug varieties (Draft for comments) No generic name dosage form specification 1 ergometrine injection 1ml: 0.2mg; 1ml: 0.5mg 2 actinomycin D injection 0.2mg 3 chlorophosphoridine Injection 2ml: 0.25g; 2ml: 0.5g; 4 corticotropin injection 25 units; 5 Digoxin oral solution 10ml: 0.5mg; 30ml: 1.5mg; 50ml: 2.5mg; 100ml: 5mg; 6 noradrenaline tartrate injection 1ml: 2mg; 2ml: 10mg 7 protamine sulfate injection 5ml: 50mg 8 compound sulfamethoxazole injection 2ml: sulfamethoxazole 0.4g, trimethoprim 80mg 9 Pingyangmycin hydrochloride injection 4mg, 8mg 10 dapsone tablets 50mg, 100mg 11 zidovudine tablets 100mg 12 zidovudine oral solution 10mg / ml 13 lamivudine tablet 150mg 14 lamivudine oral solution 10mg / ml 15 isoniazid tablet 100mg 16 p-aminosalicylate sodium injection 2.0g note: serial number 10-16 is public health medicine  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.